AKASOL AG sets price range for its IPO at EUR 48.50 to EUR 64.50 per share

• Offering of up to c. 2.1 million new shares from a capital increase and of 150,000 shares by current shareholders, including a potential over-allotment
• Net proceeds from the capital increase intended to drive organic growth, to maintain and expand a technologically leading position in e-mobility
• Free float of up to c. 40% expected
• Offer period to commence on June 18, 2018, and expected to end on June 27, 2018
• First day of trading on Prime Standard expected on June 29, 2018
Darmstadt, June 15, 2018 – AKASOL AG (“AKASOL”; the “Company”), a leading German manufacturer of high-performance lithium-ion battery systems for buses, commercial vehicles, rail vehicles, industrial vehicles, marine and stationary applications, sets price range for its envisaged IPO, aiming for total
gross proceeds of approx. EUR 100 million.
The offering will comprise a total of up to c. 2.2 million ordinary bearer shares with no par value, consisting of up to c. 2.1 million new shares from a capital increase and 150,000 existing shares offered by the current shareholders. In addition, up to 10% of the offered shares from the holdings of the current shareholders may be allocated through over-allotments (the ”Greenshoe Option“). Assuming that all new shares are placed and the Greenshoe Option is fully exercised, post-IPO free float would amount to approx. 40% of AKASOL’s share capital.
The offer period will commence on June 18, 2018, and is expected to end on June 27, 2018. The price range was set at EUR 48.50 to EUR 64.50 per share. The final offer price will be determined based on a book building process.
AKASOL CEO Sven Schulz says: ”Serial production of our high-performance battery systems for e-mobility applications such as busses and trucks is expected to start at our plant in Langen, Germany, in the third quarter of 2018, which will enable us to accelerate our growth. With the intended issue proceeds, we want to finance our growth potential, which is already clearly visible today, for example in our order backlog of EUR 1.45 billion resulting from established customer relationships with blue chip OEMs such as Daimler and a Swedish bus and truck manufacturer. We want to double our production capacity in Langen, Germany, by 2020 and plan to open a production facility in the USA in 2019 to develop the North American market.”
The capital increase will be implemented to an extent that, contingent on the final offer price, the sale of the new shares will generate gross proceeds for AKASOL of approx. EUR 100 million.
The Company intends to use the envisaged net proceeds resulting from the sale of the new shares for the expansion of the Company’s production facility in Langen, Germany, as well as for the expansion to the USA. In addition, the company intends to use the proceeds for investments in additional test and validation facilities, research and development.
AKASOL intends to list the shares on the regulated market segment of the Frankfurt Stock Exchange with simultaneous admission to the Prime Standard under the German securities code (WKN) A2JNWZ, the international securities identification number (ISIN) DE000A2JNWZ9 and the ticker symbol ASL. June 29, 2018 is expected to be the first day of trading. The lock-up period in connection with the IPO is scheduled
to last twelve months following the first day of trading for Schulz Group GmbH, Felix von Borck, Stephen Raiser and Björn Eberleh and six months following the first day of trading for the Company.
Citigroup and COMMERZBANK are acting as Joint Global Coordinators and together with Bankhaus Lampe as Joint Bookrunners. Lazard is acting as financial adviser to AKASOL.
Further information about AKASOL are available at https://www.akasol.com/investorrelations.
The securities prospectus will also be made available on AKASOL’s website, after it has been approved by the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin)).

About AKASOL:
AKASOL is a leading German manufacturer of high-performance lithium-ion battery systems for buses, commercial vehicles, rail vehicles, industrial vehicles, marine and stationary applications. Building on nearly 30 years of experience, AKASOL is a pioneer in developing, testing and manufacturing certified battery systems for the commercial transport sector.
Based in Germany, AKASOL operates a facility in Langen with an annual capacity of up to 300 MWh which is planned to be expanded to 600 MWh by 2020. To AKASOL’s knowledge, this is Europe’s largest production plant for commercial vehicle lithium-ion battery systems, currently capable of producing high-performance battery systems for up to 1,500 fully electric buses or up to 6,000 commercial vehicles per year, depending
on battery size.
AKASOL’s systems are manufactured to the industry standards demanded by leading OEM clients. Current clients include Daimler, a Swedish bus and truck manufacturer, Alstom, Bombardier, Rolls-Royce Power Systems (MTU Friedrichshafen) and Medatech. AKASOL boasts a technology-independent product portfolio. This allows the
Company to choose the best battery cells and battery chemistry according to the clients’ individual needs.

DISCLAIMER:
This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.
In the United Kingdom, this communication is directed only at persons who: (i) are qualified investors within the meaning of the Financial Services and Markets Act 2000 (as amended) and any relevant implementing measures and/or (ii) are outside the United Kingdom or (iii) have professional experience in matters relating to investments and fall within the definition of “investment professionals” contained in article 19 (5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or are persons falling within article 49 (2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Order, or fall within another exemption to the Order (all such persons referred to in (i) to (iii) above together being referred to as “Relevant Persons”). Any person who is not a Relevant Person must not act or rely on this communication or any of its contents. Any investment or investment
activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. This communication is an advertisement.
This communication constitutes neither an offer to sell nor a solicitation to buy securities. The public offering (in Germany and Luxembourg) has been made solely by means of, and on the basis of, a published securities prospectus. An investment decision regarding the publicly offered securities of AKASOL AG should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from AKASOL AG, Landwehrstraße 55, 64293 Darmstadt, Germany or on https://www.akasol.com/investor-relations.
Statements contained herein may constitute “forward-looking statements.” Forwardlooking statements are generally identifiable by the use of the words “may”, “will”, “should”, “plan”, “expect”, “anticipate”, “estimate,” “believe”, “intend”, “project”, “goal” or “target” or the negative of these words or other variations on these words or comparable terminology.
Forward-looking statements are based on current expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Group´s or its industry`s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. You should not place undue reliance on forward-looking statements and the Group does not undertake publicly to update or revise any forward-looking statement that may be made in, whether as a result of new information, future events or otherwise.